Compare Stocks: SYRA, PRPO, DCGO, and YI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DCGO DocGo	$0.40 -0.5%	$0.56	$0.35 ▼ $1.65	$39.84M	0.94	1.10 million shs	332,046 shs
PRPO Precipio	$27.40 +4.9%	$25.07	$16.00 ▼ $33.63	$49.05M	1.32	172,118 shs	114,537 shs
SYRA Syra Health	$0.93 +1.0%	$0.76	$0.05 ▼ $1.15	$12.76M	2.89	45,868 shs	12,435 shs
YI 111	$3.48 +4.4%	$3.76	$2.48 ▼ $11.17	$30.44M	0.64	9,074 shs	10,759 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DCGO DocGo	0.00%	+1.31%	-35.57%	-27.99%	-74.02%
PRPO Precipio	0.00%	-5.03%	+16.79%	+16.65%	+73.42%
SYRA Syra Health	0.00%	+16.25%	+33.54%	+82.89%	+1,309.09%
YI 111	0.00%	+0.46%	-8.28%	-27.28%	-42.07%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DCGO DocGo	$0.40 -0.5%	$0.56	$0.35 ▼ $1.65	$39.84M	0.94	1.10 million shs	332,046 shs
PRPO Precipio	$27.40 +4.9%	$25.07	$16.00 ▼ $33.63	$49.05M	1.32	172,118 shs	114,537 shs
SYRA Syra Health	$0.93 +1.0%	$0.76	$0.05 ▼ $1.15	$12.76M	2.89	45,868 shs	12,435 shs
YI 111	$3.48 +4.4%	$3.76	$2.48 ▼ $11.17	$30.44M	0.64	9,074 shs	10,759 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DCGO DocGo	0.00%	+1.31%	-35.57%	-27.99%	-74.02%
PRPO Precipio	0.00%	-5.03%	+16.79%	+16.65%	+73.42%
SYRA Syra Health	0.00%	+16.25%	+33.54%	+82.89%	+1,309.09%
YI 111	0.00%	+0.46%	-8.28%	-27.28%	-42.07%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DCGO DocGo	2.33	Hold	$2.38	489.77% Upside
PRPO Precipio	1.00	Sell	N/A	N/A
SYRA Syra Health	0.00	N/A	N/A	N/A
YI 111	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest SYRA, PRPO, DCGO, and YI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/31/2026	YI 111	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/18/2026	DCGO DocGo	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$1.00
8/18/2026	DCGO DocGo	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$3.00
8/14/2026	YI 111	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/17/2026	PRPO Precipio	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/2/2026	YI 111	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/18/2026	DCGO DocGo	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/18/2026	YI 111	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 9/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DCGO DocGo	$294.72M	0.14	$0.06 per share	7.28	$0.97 per share	0.42
PRPO Precipio	$27.20M	1.80	$0.79 per share	34.49	$8.24 per share	3.33
SYRA Syra Health	$7.98M	1.61	N/A	N/A	$0.62 per share	1.50
YI 111	$1.80B	0.02	N/A	N/A	($11.74) per share	-0.30

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DCGO DocGo	-$182.40M	-$1.96	N/A	N/A	N/A	-65.29%	-40.42%	-24.81%	11/9/2026 (Estimated)
PRPO Precipio	-$360K	-$0.64	N/A	N/A	N/A	-4.47%	-8.49%	-5.75%	11/16/2026 (Estimated)
SYRA Syra Health	-$2.94M	$0.01	N/A	N/A	N/A	-54.90%	-131.94%	-99.19%	11/18/2026 (Estimated)
YI 111	-$9.65M	-$1.40	N/A	N/A	N/A	-0.76%	N/A	-3.80%	N/A

Latest SYRA, PRPO, DCGO, and YI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/17/2026	Q2 2026	DCGO DocGo	-$0.0975	-$0.16	-$0.0625	-$0.16	$75.35 million	$73.42 million
8/14/2026	Q2 2026	PRPO Precipio	-$2.00	-$0.12	+$1.88	-$0.12	$1.68 million	$7.02 million
8/11/2026	Q2 2026	SYRA Syra Health	-$0.09	$0.02	+$0.11	N/A	$2.20 million	$2.39 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DCGO DocGo	N/A	N/A	N/A	N/A	N/A
PRPO Precipio	N/A	N/A	N/A	N/A	N/A
SYRA Syra Health	N/A	N/A	N/A	N/A	N/A
YI 111	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DCGO DocGo	N/A	1.66	1.66
PRPO Precipio	0.06	1.77	1.56
SYRA Syra Health	N/A	4.63	4.63
YI 111	N/A	1.08	0.49

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DCGO DocGo	56.44%
PRPO Precipio	10.45%
SYRA Syra Health	4.75%
YI 111	21.32%

Insider Ownership

Company	Insider Ownership
DCGO DocGo	5.10%
PRPO Precipio	16.60%
SYRA Syra Health	36.53%
YI 111	43.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DCGO DocGo	3,568	98.93 million	93.88 million	Optionable
PRPO Precipio	60	1.79 million	1.49 million	No Data
SYRA Syra Health	78	13.85 million	10.16 million	Not Optionable
YI 111	1,063	8.79 million	4.93 million	Optionable

SYRA, PRPO, DCGO, and YI Headlines

Recent News About These Companies

111 Inc. ADR

August 25, 2026 | barrons.com

Yang Luke Chen Sells 44,000 Shares of 111 (NASDAQ:YI) Stock

June 17, 2026 | insidertrades.com

111, Inc. Sponsored ADR

June 13, 2026 | edition.cnn.com

111 (NASDAQ:YI) Director Jian David Sun Sells 111,100 Shares

June 13, 2026 | insidertrades.com

111 (NASDAQ:YI) Director Jian David Sun Sells 115,440 Shares

June 12, 2026 | insidertrades.com

111: Q1 Earnings Snapshot

June 4, 2026 | khou.comK

111, Inc. Announces First Quarter 2026 Unaudited Financial Results

June 4, 2026 | prnewswire.com

Jian David Sun Sells 70,440 Shares of 111 (NASDAQ:YI) Stock

May 30, 2026 | insidertrades.com

111: Q4 Earnings Snapshot

April 9, 2026 | khou.comK

111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

April 9, 2026 | prnewswire.com

111: Q3 Earnings Snapshot

December 18, 2025 | khou.comK

111, Inc. Announces Third Quarter 2025 Unaudited Financial Results

December 17, 2025 | prnewswire.com

111: Q2 Earnings Snapshot

September 17, 2025 | houstonchronicle.comH

111, Inc. Announces Second Quarter 2025 Unaudited Financial Results

September 17, 2025 | prnewswire.com

111 Inc Share Price | NASDAQ: YI Stock - Investing.com UK

August 26, 2025 | uk.investing.com

Hua Yi Technology Falls 1.25%, Trading Volume 111 Million Yuan, Are There Opportunities in the Future?

August 26, 2025 | sohu.comS

111 Inc Stock Price Today | NASDAQ: YI Live - Investing.com

August 25, 2025 | investing.com

Driver headed to church clocked at 111 mph Sunday in Douglas County

July 21, 2025 | msn.com

MBB Team USA Dominates Team India in Game One of FISU World University Games, 111-52

July 21, 2025 | kwtx.comK

'It's a miracle!' jokes world no. 111 Haotong Li on being solo 2nd at The Open

July 21, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SYRA, PRPO, DCGO, and YI Company Descriptions

DocGo NASDAQ:DCGO

$0.40 0.00 (-0.52%)

As of 09/4/2026 04:00 PM Eastern

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Precipio NASDAQ:PRPO

$27.40 +1.28 (+4.90%)

As of 09/4/2026 04:00 PM Eastern

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

Syra Health NASDAQ:SYRA

$0.93 +0.01 (+0.98%)

As of 09/4/2026 03:42 PM Eastern

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.

111 NASDAQ:YI

$3.48 +0.15 (+4.38%)

As of 09/4/2026 03:56 PM Eastern

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SYRA, PRPO, DCGO, and YI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SYRA, PRPO, DCGO, and YI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SYRA, PRPO, DCGO, and YI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SYRA, PRPO, DCGO, and YI Company Descriptions

DocGo NASDAQ:DCGO

Precipio NASDAQ:PRPO

Syra Health NASDAQ:SYRA

111 NASDAQ:YI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SYRA, PRPO, DCGO, and YI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SYRA, PRPO, DCGO, and YI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SYRA, PRPO, DCGO, and YI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SYRA, PRPO, DCGO, and YI Company Descriptions

DocGo NASDAQ:DCGO

Precipio NASDAQ:PRPO

Syra Health NASDAQ:SYRA

111 NASDAQ:YI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools